DK1108717T3 - C-7-taxanderivater og farmaceutiske præparater indeholdende disse - Google Patents

C-7-taxanderivater og farmaceutiske præparater indeholdende disse

Info

Publication number
DK1108717T3
DK1108717T3 DK01102160T DK01102160T DK1108717T3 DK 1108717 T3 DK1108717 T3 DK 1108717T3 DK 01102160 T DK01102160 T DK 01102160T DK 01102160 T DK01102160 T DK 01102160T DK 1108717 T3 DK1108717 T3 DK 1108717T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
taxane derivatives
derivatives
taxane
Prior art date
Application number
DK01102160T
Other languages
English (en)
Inventor
Robert A Holton
Ki-Byung Chai
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/010,798 external-priority patent/US5399726A/en
Application filed by Univ Florida State filed Critical Univ Florida State
Application granted granted Critical
Publication of DK1108717T3 publication Critical patent/DK1108717T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/62Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings
DK01102160T 1993-01-29 1994-01-28 C-7-taxanderivater og farmaceutiske præparater indeholdende disse DK1108717T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/010,798 US5399726A (en) 1993-01-29 1993-01-29 Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups
US3485293A 1993-03-22 1993-03-22
US9516093A 1993-07-20 1993-07-20

Publications (1)

Publication Number Publication Date
DK1108717T3 true DK1108717T3 (da) 2003-10-13

Family

ID=27359310

Family Applications (3)

Application Number Title Priority Date Filing Date
DK02023352T DK1275389T3 (da) 1993-01-29 1994-01-28 Præparater indeholdende C7-taxaner
DK94909514T DK0681574T3 (da) 1993-01-29 1994-01-28 C7-taxanderivater og farmaceutiske præparater, der indeholder disse
DK01102160T DK1108717T3 (da) 1993-01-29 1994-01-28 C-7-taxanderivater og farmaceutiske præparater indeholdende disse

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK02023352T DK1275389T3 (da) 1993-01-29 1994-01-28 Præparater indeholdende C7-taxaner
DK94909514T DK0681574T3 (da) 1993-01-29 1994-01-28 C7-taxanderivater og farmaceutiske præparater, der indeholder disse

Country Status (12)

Country Link
EP (3) EP1108717B1 (da)
JP (2) JPH08506324A (da)
AT (3) ATE341321T1 (da)
AU (1) AU689099B2 (da)
CA (1) CA2155018C (da)
DE (3) DE69432404T2 (da)
DK (3) DK1275389T3 (da)
ES (3) ES2199901T3 (da)
IL (1) IL108443A0 (da)
PT (3) PT1108717E (da)
TW (1) TW492963B (da)
WO (1) WO1994017050A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710287A (en) 1991-09-23 1998-01-20 Florida State University Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
US5721268A (en) * 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
JPH10508022A (ja) * 1994-10-28 1998-08-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
WO1998013359A1 (de) * 1996-09-24 1998-04-02 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
ATE432928T1 (de) * 2000-02-02 2009-06-15 Univ Florida State Res Found C10-taxanester als antitumormittel
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
CA2368534A1 (en) * 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
US6362217B2 (en) 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
CA2494074A1 (en) 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
CA2119363C (en) * 1991-09-23 2001-07-17 Robert A. Holton 10-desacetoxytaxol derivatives
US5248796A (en) * 1992-06-18 1993-09-28 Bristol-Myers Squibb Company Taxol derivatives
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
IL108444A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C2 taxane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69432835T2 (de) 2004-04-22
WO1994017050A1 (en) 1994-08-04
CA2155018C (en) 2006-11-28
EP1108717A3 (en) 2001-08-29
ES2267921T3 (es) 2007-03-16
ES2191029T3 (es) 2003-09-01
CA2155018A1 (en) 1994-08-04
DE69432404D1 (de) 2003-05-08
ATE341321T1 (de) 2006-10-15
DE69432404T2 (de) 2003-10-30
JPH08506324A (ja) 1996-07-09
AU6233794A (en) 1994-08-15
EP1275389B1 (en) 2006-10-04
JP3940392B2 (ja) 2007-07-04
TW492963B (en) 2002-07-01
JP2004043499A (ja) 2004-02-12
ATE236142T1 (de) 2003-04-15
DE69432835D1 (de) 2003-07-24
IL108443A0 (en) 1994-04-12
DK0681574T3 (da) 2003-07-28
EP0681574A4 (da) 1995-12-13
EP1275389A1 (en) 2003-01-15
EP1108717A2 (en) 2001-06-20
EP0681574A1 (en) 1995-11-15
DE69434861T2 (de) 2007-04-26
PT681574E (pt) 2003-09-30
DK1275389T3 (da) 2007-02-12
ES2199901T3 (es) 2004-03-01
EP1108717B1 (en) 2003-06-18
PT1108717E (pt) 2003-11-28
AU689099B2 (en) 1998-03-26
EP0681574B1 (en) 2003-04-02
ATE243205T1 (de) 2003-07-15
DE69434861D1 (de) 2006-11-16
PT1275389E (pt) 2006-12-29

Similar Documents

Publication Publication Date Title
DK1108717T3 (da) C-7-taxanderivater og farmaceutiske præparater indeholdende disse
DE69430611T2 (de) Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
DE69703294T2 (de) Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
YU67694A (sh) Ne-peptidni antagosnisti receptora tahikinina
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
DK0912535T3 (da) Konjugater af cis-docosahexaensyre og paclitaxel
DK1146043T3 (da) Taxaner med en alkylsubstitueret sidekæde og farmaceutiske præparater indeholdende disse
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
FI930265A0 (fi) Antikoagulantpeptider
ATE401325T1 (de) C10-carbamoyloxysubstituierte taxane als antitumormittel
ATE392422T1 (de) C7-carbamoyloxysubstituierte taxane als antitumormittel
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
ATE276238T1 (de) C7-taxan-derivate und diese enthaltende pharmazeutische zusammenstellungen
DK1551850T3 (da) 2"-oxo-voruscharin og derivater deraf